PolyProx Company
PolyProx Therapeutics is a developer of a novel class of drug intended to provide new therapies for cancer treatment.
Technology:
Data-driven Technologies
Industry:
PharmTech
Headquarters:
Cambridge, Cambridgeshire, United Kingdom
Founded Date:
2019
Employees Number:
1-10
Funding Status:
Seed
Estimated Revenue:
Less than $1M
Register and Claim Ownership